Institutions / Birchview Capital, LP
Birchview Capital, LP
CIK 1618205 · Institution · as of Dec 31, 2025
Portfolio value
$170.80M
Positions
68
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 68 →
| Company | Value | % of portfolio |
|---|---|---|
| Kla Corp | $26.59M | 15.6% |
| Bristol Myers Squibb Co | $16.34M | 9.6% |
| Compass Therapeutics, Inc. | $8.55M | 5.0% |
| Stoke Therapeutics, Inc. | $8.25M | 4.8% |
| Lam Research Corp | $6.90M | 4.0% |
| Olema Pharmaceuticals, Inc. | $6.72M | 3.9% |
| Structure Therapeutics Inc.GPCR | $6.26M | 3.7% |
| Protagonist Therapeutics Inc | $4.80M | 2.8% |
| ACADIA Pharmaceuticals Inc | $4.57M | 2.7% |
| Ovintiv Inc. | $4.21M | 2.5% |
| Prothena Corp Public Ltd Co | $4.21M | 2.5% |
| Solid Biosciences Inc.SLDB | $3.98M | 2.3% |
| Neurocrine Biosciences Inc | $3.86M | 2.3% |
| Amicus Therapeutics Inc | $3.60M | 2.1% |
| Bicycle Therapeutics plcBCYC | $3.28M | 1.9% |
| Phathom Pharmaceuticals, Inc.PHAT | $3.24M | 1.9% |
| Castle Biosciences, Inc. | $3.14M | 1.8% |
| Intellia Therapeutics, Inc. | $2.84M | 1.7% |
| Immunome Inc. | $2.79M | 1.6% |
| Corcept Therapeutics Inc | $2.34M | 1.4% |
| Vera Therapeutics, Inc. | $2.23M | 1.3% |
| Quidelortho Corp | $2.07M | 1.2% |
| NovoCure Ltd | $1.97M | 1.2% |
| Biodesix Inc | $1.95M | 1.1% |
| Cytokinetics Inc | $1.91M | 1.1% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.